生物技术药物治疗系统性红斑狼疮的研究进展分析

Analysis of the research progress of biotechnology drugs in the treatment of systemic lupus erythematosus

系统性红斑狼疮是一种自身免疫性炎症性结缔组织病,对人体伤害很大。生物技术药物在系统性红斑狼疮的临床治疗中充分体现出了其安全性、有效性和把向性,从而被推广。本文对生物技术药物治疗系统性红斑狼疮的研究进展作以分析。

Systemic lupus erythematosus is a kind of autoimmune inflammatory connective tissue disease,which is very harmfulto the human body.Biotechnology drugs in the clinical treatment of systemic lupus erythematosus fully reflects its safety,effectiveness and targeting,which is promoted.In this paper,the research progress of biotechnology drugs in the treatment ofsystemic lupus erythematosus is analyzed.